Studies from Purdue and the University of Illinois point to noticeable shifts away from snacks, sweets, alcohol, and heavily processed foods, with more attention going toward protein, produce, and nutrient-dense options
These conditions can include issues such as high blood pressure, high cholesterol, or type 2 diabetes
The same risks that apply to any compounded injectable apply here: potential quality variation, dosing accuracy concerns, and lack of standardized formulations
Conclusion GLP-1 pills offer a valuable alternative for patients who resist injections or prefer daily oral medication routines
Finally, I highlight new pharmacological developments, including oral agents, and discuss important questions regarding maintenance therapy
Retrieved from Center for Drug Evaluation and Research